stars 1 stars 2 stars 3

Phenotypeca are creating a new era in Recombinant Proteins by applying proprietary QTL technology to create recombinant protein therapeutics (biosimilars), vaccines & cosmeceutical ingredients.

Phenotypeca Questions

David Frsa is the Non Executive Director of Phenotypeca.

13 people are employed at Phenotypeca.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users